Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	42,492	42,857	44,915	39,211	32,218	25,542
Revenue Growth (YoY)	-3.00%	-4.58%	14.55%	21.71%	26.14%	4.86%
Cost of Revenue	25,327	25,757	25,944	19,573	16,214	14,214
Gross Profit	17,165	17,100	18,971	19,638	16,004	11,328
Selling, General & Admin	8,509	8,445	8,993	8,007	6,930	6,144
Research & Development	1,322	1,337	1,471	1,406	1,181	1,003
Other Operating Expenses	376	459	114	197	99	-413
Operating Expenses	10,207	10,241	10,578	9,610	8,210	6,734
Operating Income	6,958	6,859	8,393	10,028	7,794	4,594
Interest Expense / Income	1,438	1,375	726	536	553	676
Other Expense / Income	-1,033	-795	14	658	16	-152
Pretax Income	6,553	6,279	7,653	8,834	7,225	4,070
Income Tax	519	284	703	1,109	850	374
Net Income	6,034	5,995	6,950	7,725	6,375	3,696
Net Income Growth	0.17%	-13.74%	-10.03%	21.18%	72.48%	25.80%
Shares Outstanding (Basic)	382	386	392	394	396	400
Shares Outstanding (Diluted)	384	388	394	397	399	403
Shares Change	-1.03%	-1.52%	-0.76%	-0.50%	-0.99%	-0.74%
EPS (Basic)	15.65	15.52	17.75	19.62	16.09	9.24
EPS (Diluted)	15.59	15.45	17.63	19.46	15.96	9.17
EPS Growth	1.63%	-12.37%	-9.40%	21.93%	74.05%	26.66%
Free Cash Flow	7,645	7,014	6,935	6,809	6,823	4,083
Free Cash Flow Per Share	20.01	18.17	17.69	17.28	17.23	10.21
Dividend Per Share	1.440	1.400	1.200	1.040	0.880	0.760
Dividend Growth	15.20%	16.67%	15.38%	18.18%	15.79%	11.76%
Gross Margin	40.40%	39.90%	42.24%	50.08%	49.67%	44.35%
Operating Margin	16.37%	16.00%	18.69%	25.57%	24.19%	17.99%
Profit Margin	14.20%	13.99%	15.47%	19.70%	19.79%	14.47%
Free Cash Flow Margin	17.99%	16.37%	15.44%	17.37%	21.18%	15.99%
Effective Tax Rate	7.92%	4.52%	9.19%	12.55%	11.76%	9.19%
EBITDA	11,374	11,060	11,760	11,962	10,103	7,023
EBITDA Margin	26.77%	25.81%	26.18%	30.51%	31.36%	27.50%
Depreciation & Amortization	3,383	3,406	3,381	2,592	2,325	2,277
EBIT	7,991	7,654	8,379	9,370	7,778	4,746
EBIT Margin	18.81%	17.86%	18.66%	23.90%	24.14%	18.58%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).